Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
BWAY
HOLDFLAGBrainsWay Ltd. · Healthcare · Israel · $641M · Avg Vol: $2M/d
BrainsWay has exceptional momentum M88 and quality Q70, but value at V14 is among the lowest in this run and far below the calibrated floor, and insiders sold, so stage one fails.
COMPANY DESCRIPTION
BrainsWay Ltd. develops and commercializes advanced non-invasive brain stimulation technology, Deep Transcranial Magnetic Stimulation (Deep TMS), for treating mental health disorders like depression and OCD. As a pioneer in Deep TMS technology, it holds FDA clearance for specific psychiatric conditions and benefits from a patented technology offering a unique treatment modality. BrainsWay is a specialized medical device company at the forefront of non-invasive neurological treatments, focused on expanding its proprietary Deep TMS platform's clinical applications.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 27.2M | 31.8M | 41.0M | 52.2M | 24.3% | 56.2M | 67.6M | 82.6M | 25.8% |
| EPS | -0.21 | -0.40 | -0.13 | 0.09 | 0.20 | 122.2% | 0.22 | 0.34 | — | 70.4% |
| Shares | — | 33.1M | 33.2M | 37.6M | 39.2M | +18.5% | 40.1M | — | — | — |
| Debt | — | 0.5M | 0.5M | 5.6M | 6.8M | 140.8% | 6.7M | — | — | — |
| Equity | — | 45.4M | 41.6M | 62.3M | 73.2M | 17.3% | — | — | — | — |
| Op CF | — | -9.8M | 1.3M | 10.3M | 18.0M | 274.6% | 13.6M | — | — | — |
| Inv CF | — | 42.2M | -37.4M | 30.3M | -17.5M | — | — | — | — | — |
| Fin CF | — | -1.5M | -1.0M | 18.3M | -2.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of BWAY are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| BWAY | BrainsWay Ltd.(you) | $641M | 51 | HOLD |
| INMD | InMode Ltd. | $872M | 93 | STRONG BUY |
| 1696.HK | Sisram Medical Ltd | $134M | 90 | STRONG BUY |
| NNOX | Nano-X Imaging Ltd. | $62M | 5 | STRONG SELL |
| SLGL | Sol-Gel Technologies Ltd. | $268M | 34 | SELL |
| DRTS | Alpha Tau Medical Ltd. | $1.1B | 27 | SELL |
| KMDA | Kamada Ltd. | $407M | 85 | STRONG BUY |
| BVC.L | BATM Advanced Communications Ltd. | $67M | 53 | HOLD |
| CGEN | Compugen Ltd. | $216M | 86 | STRONG BUY |
| INCR | InterCure Ltd. | $55M | 37 | HOLD |
Peer medians: ROE -2.9% · P/E 11.4x · Gross margin 19.6%